Review Article
Volume 12 Issue 9 - 2020
Neuromodulators for Primary Headache Disorders: A Review
Enver Salkim* and Andreas Demosthenous
Department of Electronic and Electrical Engineering, University College London, UK
*Corresponding Author: Enver Salkim, Department of Electronic and Electrical Engineering, University College London, London, UK.
Received: July 10, 2020; Published: August 29, 2020




Abstract

Primary headache disorders are among the most common and disabling globally. Pharmacological treatments are often insufficient, poorly tolerated, have side effects and the majority of patients are unable to complete their treatment. Understanding the neural pain pathways of these disorders has led to the development of alternative therapies. Electrical nerve stimulation is a form of pain modulation with few side effects for the treatment of primary headache disorders. Different neuromodulation approaches, both invasive and non-invasive, have rapidly led to new approaches for the treatment of patients suffering from headache, particularly those who have failed traditional pharmacotherapy. Non-invasive treatment methods are safe, practical and well-tolerated compared to alternatives. This paper details recent evidence-based advances in neuromodulators for primary headache disorders such as migraine and trigeminal autonomic cephalalgias (in particular, cluster headache) including non-invasive commercial devices used for migraine and cluster headache. The target neural structures, their advantages and disadvantages and their application in headache treatment are discussed. Examples of using neuromodulation to manage primary headache disorders are discussed. Both invasive stimulations e.g. of occipital and vagus nerves, the sphenopalatine ganglion, deep brain and spinal cord, and non-invasive, e.g. stimulation of the frontal, cervical and auricular vagus nerves, transcranial magnetic and transcranial direct current stimulation, are detailed.

Keywords: Cluster Headache; Migraine; Neuromodulation Devices; Neurostimulation; Primary Headache

References

  1. J Olesen. “The International Classification of Headache Disorders, 3rd edition”. Cephalalgia 38.1 (2018): 5.
  2. WZ Yeh., et al. “What is the actual prevalence of migraine?” Brain and Behaviour 8 (2018): 6-11.
  3. T Vos., et al. “Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013”. Lancet 386.9995 (2015): 743-800.
  4. R Burch., et al. “The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies”. Headache 58.4 (2018): 496-505.
  5. E Salkim. “Optimisation of a Wearable Neuromodulator for Migraine Using Computational Methods”. UCL (University College London) (2019).
  6. M Vincent and S Wang. “The International Classification of Headache Disorders, 3rd edition”. International Headache Society 38.1 (2018): 1-211.
  7. J Hoffmann and A May. “Diagnosis, pathophysiology, and management of cluster headache”. Lancet Neurol 17.1 (2018): 75-83.
  8. RB Lipton., et al. “Examination of unmet treatment needs among persons with episodic migraine: Results of the American migraine prevalence and prevention (AMPP) study”. Headache 53.8 (2013): 1300-1311.
  9. Z Hepp., et al. “Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis”. Cephalalgia 37.5 (2017): 470-485.
  10. RM Gallagher and R Kunkel. “Migraine medication attributes important for patient compliance: Concerns about side effects may delay treatment”. Headache 43.1 (2003): 36-43.
  11. RB Halker Singh., et al. “Neuromodulation for the Acute and Preventive Therapy of Migraine and Cluster Headache”. Headache 59.S2 (2019): 33-49.
  12. KD’Ostilio and D Magis. “Invasive and Non-invasive Electrical Pericranial Nerve Stimulation for the Treatment of Chronic Primary Headaches”. Current Pain and Headache Reports 20.11 (2016): 61.
  13. F Puledda., et al. “An update on migraine: current understanding and future directions”. Journal of Neurology 264.9 (2017): 2031-2039.
  14. NM Schuster and AM Rapoport. “New strategies for the treatment and prevention of primary headache disorders”. Nature Reviews Neurology 12.11 (2016): 635-650.
  15. U Reuter., et al. “Non-invasive neuromodulation for migraine and cluster headache: A systematic review of clinical trials”. Journal of Neurology, Neurosurgery, and Psychiatry 90.7 (2019): 796-804.
  16. TL Trentman and RS Zimmerman. “Occipital Nerve Stimulation: Technical and Surgical Aspects of Implantation”. Headache Current 48.2 (2007): 319-327.
  17. RL Weiner and KM Alo. “Occipital Nerve Stimulation for Treatment of Intractable Headache Syndromes”. In Neuromodulation, Elsevier (2018): 773-782.
  18. RL Weiner and KM Alo. “Occipital Nerve Stimulation for Treatment of Intractable Headache Syndromes, Second Edition. Elsevier Ltd (2018).
  19. VV Cvetkovic and RH Jensen. “Neurostimulation for the treatment of chronic migraine and cluster headache”. Neurologia 139 (2019): 4-17.
  20. T Bartsch and PJ Goadsby. “Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater”. Brain 126.8 (2003): 1801-1813.
  21. A Ashkenazi and M Levin. “Greater occipital nerve block for migraine and other headaches: Is it useful?” Current Pain and Headache Reports 11.3 (2007): 231-235.
  22. MS Matharu., et al. “Central neuromodulation in chronic migraine patients with suboccipital stimulators: A PET study”. Brain 127.1 (2004): 220-230.
  23. LA Wilbrink., et al. “Occipital nerve stimulation in medically intractable, chronic cluster headache. The ICON study: Rationale and protocol of a randomised trial”. Cephalalgia 33.15 (2013): 1238-1247.
  24. KD Ostilio and D Magis. “Invasive and Non-invasive Electrical Pericranial Nerve Stimulation for the Treatment of Chronic Primary Headaches”. Current Pain and Headache Reports 20.11 (2016).
  25. A Mauskop. “Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches”. Cephalalgia 25.2 (2005): 82-86.
  26. A Proietti Cecchini., et al. “Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: Preliminary data”. Neurological Sciences 30.1 (2009): 101-104.
  27. P Martelletti., et al. “Neuromodulation of chronic headaches: a position statement from the European Headache Federation”. The Journal of Headache and Pain 14.1 (2013): 86.
  28. MS Robbins., et al. “The Sphenopalatine Ganglion: Anatomy, Pathophysiology, and Therapeutic Targeting in Headache”. Headache 56.2 (2016): 240-258.
  29. PJ Goadsby., et al. “Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study”. Cephalalgia 38.5 (2018): 959-969.
  30. SJ Tepper., et al. “Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation: Research submission”. Headache 49.7 (2009): 983-989.
  31. SJ Tepper and A Caparso. “Sphenopalatine Ganglion (SPG): Stimulation Mechanism, Safety, and Efficacy”. Headache 57 (2017): 14-28.
  32. D Fontaine., et al. “Managing cluster headache with sphenopalatine ganglion stimulation: A review”. Journal of Pain Research 11 (2018): 375-381.
  33. CD Clelland., et al. “Common cerebral networks associated with distinct deep brain stimulation targets for cluster headache”. Cephalalgia 34.3 (2014): 224-230.
  34. H Akram., et al. “Optimal deep brain stimulation site and target connectivity for chronic cluster headache”. Neurology 91.4 (2018): 194.
  35. T Wolter., et al. “High cervical spinal cord stimulation for chronic cluster headache”. Cephalalgia 31.11 (2011): 1170-1180.
  36. NM Schuster and AM Rapoport. “New strategies for the treatment and prevention of primary headache disorders”. Nature Reviews Neurology 12.11 (2016): 635-650.
  37. R De Agostino., et al. “High-Cervical Spinal Cord Stimulation for Medically Intractable Chronic Migraine”. Neuromodulation 18.4 (2015): 289-296.
  38. MS Robbins and RB Lipton. “Transcutaneous and Percutaneous Neurostimulation for Headache Disorders”. Headache 57 (2017): 4-13.
  39. AJ Sinclair., et al. “Headache management: pharmacological approaches”. Practical Neurology 15.6 (2015): 411-423.
  40. E Salkim., et al. “Impact of neuroanatomical variations and electrode orientation on stimulus current in a device for migraine: a computational study”. Journal of Neural Engineering 17.1 (2019): 016006.
  41. F Riederer., et al. “Transcutaneous Supraorbital Nerve Stimulation (t-SNS) with the Cefaly(®) Device for Migraine Prevention: A Review of the Available Data”. Pain and Therapy 4.2 (2015): 135-147.
  42. S Miller and MS Matharu. “The use of electroceuticals and neuromodulation in the treatment of migraine and other headaches”. In Electroceuticals: Advances in Electrostimulation Therapies (2017): 1-33.
  43. A Straube., et al. “Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trial”. The Journal of Headache and Pain 16 (2015): 543.
  44. R Bhola., et al. “Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program”. The Journal of Headache and Pain 16 (2015): 535.
  45. A Przeklasa-Muszyńska., et al. “Transcranial direct current stimulation (tDCS) and its influence on analgesics effectiveness in patients suffering from migraine headache”. Pharmacological Reports 69.4 (2017): 714-721.
  46. H Matsumoto and Y Ugawa. “Adverse events of tDCS and tACS: A review”. Clinical Neurophysiology Practice 2 (2017): 19-25.
Citation: Enver Salkim and Andreas Demosthenous. “Neuromodulators for Primary Headache Disorders: A Review”. EC Neurology 12.9 (2020): 223-236.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


December Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the December issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 20, 2021.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk